Chronic pain after herniorraphy pregabalin versus placebo.
Completed
- Conditions
- Patients suffering from chronic pain of neuropathic character after unilateral open inguinal hernia repair.
- Registration Number
- NL-OMON20871
- Lead Sponsor
- Pfizer bv
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 122
Inclusion Criteria
1. History of unilateral inguinal herniotomy;
2. Establishment of neuropathic character of chronic pain by means the LANSS painscore and DN4 score;
Exclusion Criteria
1. Participation in another trial;
2. Bilateral hernia;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is the mean 11-point numerical pain rating score in both treatment groups at baseline and follow-up.
- Secondary Outcome Measures
Name Time Method The secondary outcomes are the mean light-touch and thermal QST thresholds between the painful inguinal area and the normal contra-lateral side in patients from both treatment groups at baseline and follow-up.